Komori
Kidswell Bio (4584) · TargetRestated

Early Profitability and Strengthening the Financial Condition

First written in FY2016. 15 of 25 entries say "Restated". Latest entry: 2026-08-13.

25entries
11years
6from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2020RestatedFY2024-Q32016: 120162017: 120172018: 120182019: 120192020: 120202021: 420212022: 420222023: 220232024: 120242025: 220252026: 72026
Same theme, other companies
Stable earnings power and improvements in financial positionA theme 58 companies write about · 0 as a headwind · 59 as a tailwind

The whole theme swung hardest in 2020: 10 of 45 companies on the "Worse" side.

19 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 58 companies compared. The sentences above are computed from all 58.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「In the following consolidated fiscal year, we expect to achieve a consolidated operating profit as initially planned because revisions to supply prices and the switch to products with lower manufacturing costs will contribute for the full year.」

    The company maintains its target of stable consolidated operating profitability from FY2026 onward and indicates that it expects to achieve this in the following consolidated fiscal year through the full-year contribution of revised supply prices and lower-cost products.
  2. FY2026-H1AdvancedAnnual report

    「During the interim consolidated accounting period, our group recorded operating income.」

    While targeting stable consolidated operating profitability, the group recorded operating income for the interim consolidated accounting period. It also states that period profit may temporarily turn negative as a result of future research and development investment.
  3. FY2025AdvancedAnnual report

    「Our group is working to strengthen its earnings base with the aim of achieving stable consolidated operating profitability from FY2026 onward.」

    Regarding the target of achieving profitability early, the company specified FY2026 onward as the timing for achieving stable consolidated operating profitability. Although it recorded its first company-wide operating profit since listing in the current fiscal year, it has not yet achieved stable consolidated profitability.
  4. FY2024-Q3RestatedAnnual report

    「While promoting the medium-term management plan, KWB2.0, announced on 12 May 2022, we are committed to the specific future strategic policies and performance targets for each of the businesses described above and are strengthening our activities for further growth.」

    The company has reaffirmed its policy of pursuing the strategic policies and performance targets for each business under the medium-term management plan, KWB2.0.
  5. FY2024-Q2AdvancedAnnual report

    「In addition, GBS-010, a pegfilgrastim biosimilar developed jointly with Mochida Pharmaceutical Co.,Ltd. since December 2016 as the fourth biosimilar following the three products described above, received marketing approval in September 2023. Sales are scheduled to begin by the end of 2023, and the company is expected to make steady progress toward achieving the FY2025 performance targets set out in the medium-term management plan, KWB2.0, announced in May 2022, alongside further revenue growth from the four products already launched, including GBS-007, for which an additional indication was approved in September 2023.」

    The company describes approval of GBS-010 and its four-product launched portfolio as concrete progress toward the FY2025 performance targets under KWB2.0.
  6. FY2023-Q3RestatedAnnual report

    「Under these circumstances, on 12 May 2022 we announced a new medium-term management plan, KWB2.0, committed to specific future strategic policies and performance targets for each of the businesses described above, and are strengthening our activities for further growth.」

    The company has reaffirmed its policy of strengthening activities toward achieving the strategic policies and performance targets for each business under the medium-term management plan, KWB2.0.
  7. FY2023-Q2RestatedAnnual report

    「Under these circumstances, on 12 May 2022 we announced a new medium-term management plan, KWB2.0, committed to specific future strategic policies and performance targets for each of the businesses described above, and are strengthening our activities for further growth.」

    The company has reaffirmed its policy of strengthening activities toward achieving the specific strategic policies and performance targets for each business under the medium-term management plan, KWB2.0.
  8. FY2023-Q1RestatedAnnual report

    「Under these circumstances, on 12 May 2022 we announced a new medium-term management plan, KWB2.0, committed to specific future strategic policies and performance targets for each of the businesses described above, and are strengthening our activities for further growth.」

    The company has reaffirmed its policy of strengthening activities toward achieving the specific strategic policies and performance targets for each business under the medium-term management plan, KWB2.0.
  9. FY2022ReframedAnnual report

    「Under these circumstances, on 12 May 2022 we announced a new medium-term management plan, KWB2.0, committed to specific future strategic policies and performance targets for each of the businesses described above, and are strengthening our activities for further growth.」

    The previous five-year plan for achieving early profitability and growth has been reorganized and announced as the new medium-term management plan, KWB2.0, setting out strategic policies and performance targets for each business.
  10. FY2022-Q3RestatedAnnual report

    「To ensure achievement of the specific future strategic policies and performance targets for each business under the five-year medium-term management plan announced on 15 February 2021, we are renewing our efforts and strengthening activities across the company.」

    The company has reaffirmed its efforts to strengthen activities toward achieving the strategic policies and performance targets under the five-year medium-term management plan announced in February 2021.
  11. FY2022-Q2RestatedAnnual report

    「To ensure achievement of the specific future strategic policies and performance targets for each business under the five-year medium-term management plan announced on 15 February 2021, we are renewing our efforts and strengthening activities across the company.」

    The company has reaffirmed its efforts to strengthen activities toward achieving the strategic policies and performance targets under the five-year medium-term management plan announced in February 2021.
  12. FY2022-Q1RestatedAnnual report

    「To ensure achievement of the specific future strategic policies and performance targets for each business under the five-year medium-term management plan announced on 15 February 2021, we are renewing our efforts and strengthening activities across the company.」

    The company has reaffirmed its efforts to strengthen activities toward achieving the strategic policies and performance targets for each business under the five-year medium-term management plan announced in February 2021.
  13. FY2021AdvancedAnnual report

    「Under these circumstances, on 15 February 2021 we announced a five-year medium-term management plan, committed to specific future strategic policies and performance targets for each of the businesses described above, and are strengthening our activities for further growth.」

    Regarding the medium-term management plan for achieving profitability early, the company reached the scheduled announcement period and progressed to the stage of announcing the five-year plan and specific strategic policies and performance targets for each business.
  14. FY2021-Q3AdvancedAnnual report

    「Regarding the medium-term management plan for achieving profitability early, announced in the supplementary materials to the financial results for the second quarter of the fiscal year ending March 2021 dated 6 November 2020, we set 15 February 2021 as the planned announcement date and are currently reviewing its details.」

    Regarding the medium-term management plan for achieving profitability early, the company progressed to the stage of reviewing its details and setting 15 February 2021 as the planned announcement date.
  15. FY2020RestatedAnnual report

    「We aim to achieve profitability early, but if the business plan does not progress as expected, the timing of profitability may be delayed, as may the timing of accumulated retained earnings turning from negative to positive.」

    The company has reaffirmed its target of achieving profitability early and the possibility that the timing of achievement may be delayed depending on progress under the business plan.
  16. FY2019RestatedAnnual report

    「We aim to achieve profitability early, but if the business plan does not progress as expected, the timing of profitability may be delayed, as may the timing of accumulated retained earnings turning from negative to positive.」

    The company has reaffirmed its target of achieving profitability early and the possibility that the timing may be delayed depending on progress under the business plan.
  17. FY2018RestatedAnnual report

    「We aim to achieve profitability early, but if the business plan does not progress as expected, the timing of profitability may be delayed, as may the timing of accumulated retained earnings turning from negative to positive.」

    The company has stated that it continues to target early profitability, while noting that the timing of achievement depends on progress under the business plan.
  18. FY2017RestatedAnnual report

    「We aim to achieve profitability early, but if the business plan does not progress as expected, the timing of profitability may be delayed, as may the timing of accumulated retained earnings turning from negative to positive.」

    The company has stated that it continues to target early profitability, while noting that the timing of achievement depends on progress under the business plan.
  19. FY2016First statedAnnual report

    「We aim to achieve profitability early.」

    As a research-driven company with research and development expenses incurred ahead of revenue, the company has set profitability as a goal. No specific fiscal year or profit amount has been disclosed.
Moved together

"Securing a Competitive Product Advantage through Active Pharmaceutical Ingredient Quality, Manufacturing Costs, and Usability" moved the same way as this thread, in the same document, in 4 of its 25 moves.

443333★123456
  1. ★This thread
  2. 1Securing a Competitive Product Advantage through Active Pharmaceutical Ingredient Quality, Manufacturing Costs, and Usability4×
  3. 2Four-party joint research on a treatment for cerebral palsy using dental pulp stem cells4×
  4. 3A Hybrid Business Model Building Stability through Biosimilars and Pursuing Growth through Novel Biologics3×
  5. 4Equity Financing-Centered Fundraising and Dilution of Share Value3×
  6. 5Initiation of company-led clinical trials from 2025 onward3×
  7. 6Enhancing Development Capabilities and Speed Through Partnerships with Contract Research Organizations and Pharmaceutical Companies3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Kidswell Bio yet. It last moved in the Presentation materials on financial results of 2026-08-13: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Early Profitability and Strengthening the Financial Condition | Kidswell Bio Corporation (4584) | Komori